Upton, Coburn Letter to FDA Regarding OxyContin

May 3, 2013

Excerpt: We write in strong support of the Food and Drug Administration's (FDA) announcement to apply a "removed for safety or efficacy" determination to the crushabale form of OxyContin. This decision by FDA will help mitigate the harmful effects of the nation's prescription drug abuse crisis. inculding the suffering it causes in families across our country.

To read the letter, click here.

Letter Type: